Position in ANNX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$4,227,045
-$654,647 QoQ
Shares Held
763,005
-21.5% QoQ
Ownership
0.382%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 99.5879450331256.ToString("F0")%
None 0.41205496687439797.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. ANNX ranks #86 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in ANNX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,227,045 | 763,005 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $4,881,692 | 972,449 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $615,931 | 201,945 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $360,992 | 150,414 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $176,418 | 91,409 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $163,547 | 31,881 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $125,917 | 21,270 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $111,905 | 22,838 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,657,444 | 789,044 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $98,844 | 21,772 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $43,638 | 18,491 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $64,985 | 18,462 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $259,859 | 50,263 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $312,640 | 50,589 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $200,726 | 53,243 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $146,310 | 53,594 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $128,238 | 11,161 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $242,002 | 13,004 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $265,279 | 11,785 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||